secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001104659-23-073405
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics shareholders approve reverse split, equity plan; preferred converts to 24M shares
--------------------------------------------------------------------------------

- Directors Loscalzo, Mashiach, Mirabelli elected as Class III directors at annual meeting.
- Advisory vote on executive compensation approved; frequency set to annual until 2029.
- Amendment to 2022 Equity Incentive Plan and reverse stock split approved by shareholders.
- Series X Non-Voting Convertible Preferred Stock conversion effective June 21, after approval.
- Post-conversion and reverse split, common shares outstanding: 24,005,499.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923073405/0001104659-23-073405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923073405/tm2319369d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-073405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer